SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-23
👔
ArriVent BioPharma, Inc.
@AVBP_InsiderForm 4 Filing: Hohneker John Acquires (Grant) shares of $AVBP
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
ArriVent BioPharma, Inc.
Ticker: $AVBP
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-18
Shares: 13,562
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Hohneker John, holds the title of Director at ArriVent BioPharma, Inc..
On 2026-06-18, the insider transacted 13,562 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Hohneker John (Director) was granted $0 of $AVBP
Post-Transaction Position: 13,562 shares
SEC Accession No: 0001104659-26-076567 (CIK: 1695378)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.